Home
AUROPHARMA.NS

Aurobindo Pharma Limited

NSEHealthcare
₹1,613.60
+3.37%+₹52.60 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹1,561.00
Day range
₹0 – ₹0
52W range
₹1,016.1 – ₹1,636.8
Volume
21.9L
Avg vol (20D)
15.7L
Mkt cap
₹93,239.99Cr
P/E TTM
26.8×

Trade Aurobindo Pharma Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹33653.08 Cr
Net Income (ttm)₹0.00
Shares Out57.54 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.02

About AUROPHARMA.NS

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolAUROPHARMA.NS
AUROPHARMA.NS · NSE
Financial Performance

In 2026, Aurobindo Pharma Limited's revenue was ₹33653.08 Cr, an increase of +5.60% compared to the previous year. Earnings were ₹0.00, an increase of +1.90%.

Revenue (2026)
₹33653.08 Cr
+5.60% YoY
Earnings (2026)
₹0.00
+1.90% YoY
Year-over-Year Growth
Revenue
+5.60%
Earnings
+1.90%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.